Emergent BioSolutions Inc. Financial Ratios — EBS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	12.42	11.27	13.19	13.61	19.66	17.1	27.92	17.8	13.81	53.23	26.17	-25.05	- -	- -	- -
Return on Assets (%)	4.4	4.23	5.23	4.69	6.36	5.16	8.1	3.8	2.39	11.74	7.52	-6.91	-30.48	-11.86	3.88
Return on Capital (%)	12.36	10.65	10.72	9.87	11.83	10.1	19.97	9.3	6.81	23.21	14.41	- -	- -	- -	20.9
Return on Invested Capital (%)	3.61	4.56	5.65	8.48	11.14	7.51	9.67	5.05	4.33	15.42	11.63	- -	- -	- -	6.33
Gross Margin (%)	79.17	78.66	75.91	67.4	71.1	63.43	61.73	54.31	55.92	63.27	54.37	35.59	31.05	32.78	53.74
EBITDA Margin (%)	20.48	23.52	23.95	38.89	47.55	41.6	34.03	21.55	22.86	37.82	30.92	-1.86	-7.47	2.69	29.51
Operating Margin (%)	15.86	18.33	16.59	28.51	38.05	30.54	25.35	12.73	11.6	29.99	23.37	-15.18	-19.7	-8.04	15.92
Incremental Operating Margin (%)	84.66	55.44	7.69	84.54	88.47	135.71	12.97	-16.05	8.74	67.77	-31.26	- -	- -	- -	-62.84
Pretax Margin (%)	15.78	14.85	16.81	26.92	36.49	28.72	24.18	11.55	7.87	28.17	18.49	-20.35	-71.48	-14.1	11.74
Profit Margin (%)	11.37	10.9	12.07	11.75	16.9	15	16.84	8.89	5.54	20.91	13.39	-19.66	-74.34	-18.8	7.46
Net Income to Common Margin (%)	11.37	10.9	12.07	11.75	16.9	15	16.84	8.89	5.54	20.91	13.39	-19.66	-74.34	-18.8	7.46
Effective Tax Rate (%)	49.56	43.42	30.23	35.55	32.64	37	30.35	23.07	29.59	25.76	27.61	- -	- -	- -	36.47
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	12.42	11.27	13.19	13.61	19.66	17.1	27.92	17.8	13.81	53.23	26.17	-25.05	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	59	63	62	251	247	268	14	795	811	875	841	1,406	860	664	572
ST Debt	5	4	- -	- -	- -	20	- -	10	13	34	32	957	414	- -	- -
LT Debt	54	58	62	251	247	248	14	784	798	841	809	448	446	664	572
Total Debt/EBITDA	1.43	1.24	1	2.06	1.4	1.87	0.08	5.23	3.61	1.58	1.66	-70.29	-11.26	24.31	2.75
Net Debt/EBITDA	-2.04	-1.55	-1.9	-0.24	-0.35	-0.02	-0.99	4.49	2.86	0.46	0.52	-38.16	-9.8	20.67	1.76
Total Debt/EBIT	1.85	1.59	1.45	2.81	1.74	2.54	0.11	8.85	7.11	1.99	2.2	-8.61	-4.27	-8.14	5.09
Net Debt/EBIT	-2.63	-1.99	-2.74	-0.33	-0.43	-0.03	-1.33	7.6	5.64	0.58	0.69	-4.67	-3.71	-6.92	3.27
EBITDA to Interest Expense	- -	8,460.67	- -	14.76	27.11	18.91	25.29	15.35	5.85	17.67	14.69	-0.54	-0.87	0.38	3.51
EBITDA-CapEx/Interest Expense	- -	-513.5	- -	11.04	20.24	8.88	16.98	8.07	3.59	13.13	8.2	-4.23	-1.46	0.06	3.28
EBIT to Interest Expense	- -	6,594.5	- -	10.82	21.69	13.88	18.83	9.07	2.97	14.01	11.1	-4.38	-2.29	-1.15	1.89
Interest Expense	- -	- -	- -	8	7	8	7	10	38	31	34	37	88	71	59
Common Equity/Total Assets	36.01	39.07	40.15	30.71	33.85	26.24	31.51	16.48	18.13	25.22	32.13	23.33	-1.19	-15.28	-12.11
Long-Term Debt/Equity (%)	12.98	13.19	12.67	45.37	37.41	41.61	1.48	77.6	73.35	58.12	50.23	32.32	68.77	137.47	109.47
Long-Term Debt/Capital (%)	20.9	20.53	19.8	46.54	41.28	47.47	3.85	67.51	64.74	52.5	45.18	20.91	53.25	147.03	138.72
Long-Term Debt/Total Assets (%)	9.89	10.33	9.89	26.74	23.8	25.57	1.26	35.19	34.31	29.17	27.37	14.16	24.49	47.76	43.39
Total Debt/Equity (%)	14.27	14.2	12.67	45.37	37.41	44.97	1.48	78.6	74.53	60.46	52.19	101.3	132.48	137.47	109.47
Total Debt/Capital (%)	22.97	22.11	19.8	46.54	41.28	51.3	3.85	68.38	65.79	54.61	46.95	65.55	102.59	147.03	138.72
Total Debt/Total Assets (%)	10.87	11.13	9.89	26.74	23.8	27.64	1.26	35.64	34.86	30.34	28.43	44.4	47.18	47.76	43.39
Net Debt to Equity	-20.26	-17.84	-23.99	-5.33	-9.3	-0.57	-18.06	67.5	59.12	17.52	16.44	55	115.28	116.86	70.17
Net Debt/Capital (%)	-73.47	-55.44	-87.71	-11.4	-21.19	-1.36	-95.59	65	60.4	25.85	21.8	50.81	102.99	160.33	177.15
EBITDA	41	51	62	122	177	144	167	152	225	553	507	-20	-76	27	208
EBITDA-CapEx	-13	-3	20	91	132	68	112	80	138	411	283	-158	-128	4	194
Operating Income (Loss)	32	40	43	89	142	106	124	90	114	438	383	-163	-202	-82	112

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.05	2.29	3.17	3.02	3.1	2.56	1.78	0.56	0.78	1.62	1.54	0.52	0.17	0.61	1.55
Current Ratio	3.58	4.25	4.82	4.65	5.4	4.82	4.85	3.1	3.17	3.11	3.4	0.98	1.04	3.69	5.01
Quick Ratio	3.23	3.84	4.33	3.67	4.3	3.97	3.24	1.91	2.03	2.22	2.29	0.65	0.46	1.56	2.19
CFO/Avg Current Liab	0.17	0.6	1.64	1.5	0.44	0.53	2.02	0.28	0.9	1.79	0.84	-0.04	-0.22	0.14	1.16
Common Equity/Total Assets	36.01	39.07	40.15	30.71	33.85	26.24	31.51	16.48	18.13	25.22	32.13	23.33	-1.19	-15.28	-12.11
Long-Term Debt/Equity (%)	12.98	13.19	12.67	45.37	37.41	41.61	1.48	77.6	73.35	58.12	50.23	32.32	68.77	137.47	109.47
Long-Term Debt/Capital (%)	20.9	20.53	19.8	46.54	41.28	47.47	3.85	67.51	64.74	52.5	45.18	20.91	53.25	147.03	138.72
Long-Term Debt/Total Assets (%)	9.89	10.33	9.89	26.74	23.8	25.57	1.26	35.19	34.31	29.17	27.37	14.16	24.49	47.76	43.39
Total Debt/Equity (%)	14.27	14.2	12.67	45.37	37.41	44.97	1.48	78.6	74.53	60.46	52.19	101.3	132.48	137.47	109.47
Total Debt/Capital (%)	22.97	22.11	19.8	46.54	41.28	51.3	3.85	68.38	65.79	54.61	46.95	65.55	102.59	147.03	138.72
Total Debt/Total Assets (%)	10.87	11.13	9.89	26.74	23.8	27.64	1.26	35.64	34.86	30.34	28.43	44.4	47.18	47.76	43.39
CFO/Total Liabilities	9.36	32.47	70.54	29.14	11.26	14.6	131.79	3.43	15.18	37.38	23.79	-1.92	-17.57	6.47	21.43
CFO/CapEx	0.23	0.74	2.31	3.66	0.95	0.72	3.8	0.58	2.16	3.78	1.43	-0.25	-4	2.56	12.36
Altman's Z-Score	4.41	4.58	5.5	3.43	4.4	3.83	9.42	3.21	3.25	4.48	3.53	0.9	0.35	1.43	2.19

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.28	3.29	4.23	7.3	5.48	3.71	4.69	4	4.26	7.31	8.13	6.46	8.37	7.31	6.98
Days Sales Outstanding	85.22	111.03	86.26	50.01	66.58	98.37	77.9	91.3	85.6	49.92	44.88	56.51	43.62	49.91	52.33
Inventory Turnover	3.08	3.09	4.17	2.54	1.7	1.87	1.73	1.85	2.02	2.03	2.3	1.99	2.08	2.13	1
Days Inventory Outstanding	118.5	118.12	87.55	143.76	214.89	194.91	210.8	197.39	180.31	179.95	158.93	183.05	175.83	171.6	366.51
Accounts Payable Turnover	1.34	1.3	2.09	4.47	2.6	3.84	6.71	6.29	5.13	5.38	5.93	6.02	6.34	7.67	6.14
Accounts Payable Turnover Days	272.81	281.44	174.23	81.65	140.21	95.06	54.39	58.02	71.14	67.8	61.56	60.65	57.59	47.57	59.41
Cash Conversion Cycle	-69.09	-52.28	-0.42	112.11	141.26	198.22	234.31	230.67	194.77	162.07	142.26	178.91	161.86	173.94	359.43
Inventory to Cash Days	-33.29	-7.08	-1.29	-93.75	-148.31	-96.54	-132.89	-106.09	-94.71	-130.03	-114.05	-126.54	-132.21	-121.69	-314.18
Inventories	15	15	15	66	61	74	143	206	222	307	344	351	329	312	343
Raw Materials	2	3	3	17	21	31	36	52	70	161	213	142	129	96	121
Work In Process	10	10	10	33	33	20	77	103	90	102	96	116	113	86	109
Finished Goods	2	3	2	15	7	23	30	51	62	44	36	92	87	130	114
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	600	579	832	1,017	1,544	1,320	1,943	2,970	2,778	4,722	2,326	592	123	507	661
- Cash & Cash Equivalents	144	142	179	280	308	272	178	112	168	621	576	643	112	100	205
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	2	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	59	63	62	251	247	268	14	795	811	875	841	1,406	860	664	572
Enterprise Value	517	501	714	987	1,483	1,316	1,778	3,652	3,422	4,975	2,591	1,355	871	1,071	1,028
Total Capital	259	284	313	539	598	523	351	1,162	1,233	1,602	1,791	2,145	838	451	412
Total Debt/Capital (%)	22.97	22.11	19.8	46.54	41.28	51.3	3.85	68.38	65.79	54.61	46.95	65.55	102.59	147.03	138.72
Total Debt / EV	0.12	0.13	0.09	0.25	0.17	0.2	0.01	0.22	0.24	0.18	0.32	1.04	0.99	0.62	0.56
EV/Sales	2.55	2.32	2.77	3.16	3.99	3.81	3.63	5.18	3.48	3.4	1.58	1.26	0.85	1.06	1.46
EV/EBITDA	12.46	9.86	11.57	8.12	8.38	9.16	10.66	24.03	15.22	9	5.11	- -	- -	39.23	4.94
EV/EBIT	16.09	12.65	16.69	11.07	10.48	12.48	14.31	40.67	29.99	11.35	6.76	- -	- -	- -	9.15
EV/Cash Flow to Firm	42.39	12.63	7.37	8.39	31.61	22.16	8.36	73.91	15.91	8.88	7.5	698.52	- -	6.98	4.94
EV/Free Cash Flow to Firm	7.8	5.35	5.14	6.66	16.17	9.71	6.65	30.06	11.33	7.09	4.55	9.71	- -	6.07	4.63
Diluted Market Cap	610	584	845	1,247	1,891	1,620	2,339	3,047	2,827	4,820	2,352	592	123	507	701
Diluted Enterprise Value	528	506	727	1,218	1,829	1,617	2,174	3,729	3,470	5,074	2,617	1,355	871	1,071	1,068
EV per Share	14.49	13.87	19.74	26.44	38.42	32.75	42.53	72.9	66.45	94.41	48.42	27.04	17.02	20.21	19.21
TTM Sales	202	216	258	313	372	345	490	705	984	1,462	1,639	1,076	1,023	1,014	705
TTM EBITDA	41	51	62	122	177	144	167	152	225	553	507	-20	-76	27	208
TTM Operating Income	32	40	43	89	142	106	124	90	114	438	383	-163	-202	-82	112
TTM Cash Flow to Firm	12	40	97	118	47	59	213	49	215	560	345	2	-115	153	208
TTM Free Cash Flow to Firm	66	93	139	148	92	136	267	122	302	702	569	140	-63	176	222

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	9.21	6.25	6.08	8.72	21.65	12.39	8.9	26.75	10.28	7.1	4.32	5.72	-0.79	6.21	3.8
EV/EBIT	16.09	12.65	16.69	11.07	10.48	12.48	14.31	40.67	29.99	11.35	6.76	- -	- -	- -	9.15
Enterprise Value	517	501	714	987	1,483	1,316	1,778	3,652	3,422	4,975	2,591	1,355	871	1,071	1,028
Low Price	14.9	12.5	13.02	19.31	25.97	24.47	27.94	42.66	39.11	46.37	29.88	10.61	1.81	1.42	4.02
EV/Sales	2.55	2.32	2.77	3.16	3.99	3.81	3.63	5.18	3.48	3.4	1.58	1.26	0.85	1.06	1.46
EV/EBITDA	12.46	9.86	11.57	8.12	8.38	9.16	10.66	24.03	15.22	9	5.11	- -	- -	39.23	4.94
Price/Earnings	26.09	24.6	26.73	27.68	24.56	25.48	23.53	47.37	50.98	15.44	10.6	- -	- -	- -	12.57
Price/Earnings Average	31.62	23.15	20.04	24.2	19.59	25.9	17.68	44.92	49.01	14.33	16.51	-7.18	-0.49	-1.74	8.28
Price/Earnings High	40.91	28.13	27.95	28.95	24.86	34.43	24.25	59.04	63.74	23.72	31	-12.38	-1.12	-4.2	13.64
Price/Earnings Low	23.08	19.17	15.14	19.63	15.94	18.98	14.14	34.09	36.96	7.99	7.28	-2.51	-0.12	-0.39	4.09
Price/Book Value	3.05	2.63	3.31	3.53	4.4	5.18	5.76	8.08	6.59	6.5	2.45	0.8	-5.66	-2.39	-4.14
Price/Book Value Average	3.7	2.47	2.48	3.08	3.51	5.27	4.33	7.67	6.33	6.03	3.81	2.06	-17.19	-1.56	-2.73
Price/Book Value High	4.78	3	3.46	3.69	4.45	7.01	5.94	10.08	8.23	9.98	7.16	3.55	-39.32	-3.77	-4.49
Price/Book Value Low	2.7	2.05	1.87	2.5	2.85	3.86	3.46	5.82	4.77	3.36	1.68	0.72	-4.27	-0.35	-1.35
Price/Tangible Book Value	1.67	1.47	2.06	2.66	2.67	2.53	2.61	-49.17	34.73	9.13	2.97	1.34	1.49	-27.1	7.68
Price/Tangible Book Value Average	2.02	1.38	1.55	2.33	2.13	2.57	1.96	-46.64	33.39	8.47	4.63	3.45	4.51	-17.74	5.06
Price/Tangible Book Value High	2.62	1.68	2.16	2.79	2.71	3.42	2.69	-61.29	43.42	14.02	8.7	5.94	10.32	-42.8	8.33
Price/Tangible Book Value Low	1.48	1.14	1.17	1.89	1.74	1.89	1.57	-35.39	25.18	4.72	2.04	1.21	1.12	-4.02	2.5
Price/Sales	2.97	2.68	3.23	3.25	4.15	3.82	3.96	4.21	2.83	3.23	1.42	0.55	0.12	0.5	0.94
Price/Sales Average	3.6	2.52	2.42	2.84	3.31	3.88	2.98	3.99	2.72	3	2.21	1.41	0.36	0.33	0.62
Price/Sales High	4.65	3.07	3.37	3.4	4.2	5.16	4.08	5.25	3.53	4.96	4.15	2.43	0.83	0.79	1.02
Price/Sales Low	2.62	2.09	1.83	2.31	2.69	2.85	2.38	3.03	2.05	1.67	0.98	0.49	0.09	0.07	0.3
Price/Cash Flow	49.28	14.6	8.58	9.05	36.32	24.17	9.34	71.05	14.78	8.79	7.26	-17.35	-0.6	8.63	3.88
Price/Cash Flow Average	59.73	13.74	6.43	7.91	28.97	24.57	7.02	67.39	14.21	8.16	11.32	-44.53	-1.81	5.65	2.55
Price/Cash Flow High	77.29	16.69	8.97	9.47	36.76	32.66	9.63	88.56	18.48	13.51	21.25	-76.81	-4.14	13.63	4.21
Price/Cash Flow Low	43.6	11.38	4.86	6.42	23.57	18.01	5.61	51.14	10.71	4.55	4.99	-15.59	-0.45	1.28	1.26
Price/Free Cash Flow Average	11.16	5.88	4.56	7.63	17.27	12.59	6.68	25.37	9.89	6.59	6.73	14.67	-2.41	4.07	2.5
Price/Free Cash Flow High	14.44	7.14	6.35	9.12	21.91	16.74	9.17	33.34	12.86	10.91	12.64	25.31	-5.52	9.81	4.12
Price/Free Cash Flow Low	8.15	4.87	3.44	6.19	14.05	9.23	5.35	19.25	7.45	3.68	2.97	5.14	-0.6	0.92	1.24
EV/Sales Average	3.19	2.16	1.96	2.75	3.15	3.87	2.64	4.96	3.37	3.17	2.37	2.12	1.1	0.88	1.14
EV/Sales High	4.25	2.7	2.92	3.31	4.04	5.15	3.75	6.22	4.19	5.13	4.31	3.14	1.57	1.35	1.54
EV/Sales Low	2.22	1.73	1.37	2.21	2.53	2.84	2.05	4	2.7	1.84	1.14	1.2	0.82	0.63	0.82
EV/EBITDA Average	15.58	9.19	8.2	7.07	6.62	9.31	7.76	23.02	14.74	8.38	7.67	-114.08	-14.68	32.82	3.85
EV/EBITDA High	20.74	11.5	12.18	8.5	8.49	12.39	11.01	28.84	18.31	13.57	13.95	-169.12	-20.96	49.98	5.21
EV/EBITDA Low	10.84	7.35	5.72	5.69	5.32	6.82	6.01	18.55	11.82	4.88	3.68	-64.74	-11.01	23.42	2.8
EV/EBIT Average	20.12	11.79	11.83	9.64	8.27	12.68	10.42	38.97	29.05	10.57	10.15	-13.97	-5.57	-10.99	7.14
EV/EBIT High	26.79	14.75	17.58	11.59	10.61	16.87	14.79	48.82	36.08	17.12	18.45	-20.71	-7.95	-16.74	9.65
EV/EBIT Low	14	9.42	8.26	7.75	6.65	9.29	8.07	31.4	23.29	6.15	4.86	-7.93	-4.17	-7.85	5.18
Last Price	16.84	16.04	22.99	27.23	40.01	32.84	46.47	59.28	53.95	89.6	43.47	11.81	2.4	9.56	12.36
High Price	26.41	18.34	24.04	28.48	40.49	44.38	47.9	73.89	67.45	137.61	127.2	52.28	16.66	15.1	13.41
Enterprise Value Average	646	466	506	859	1,170	1,338	1,295	3,499	3,315	4,636	3,888	2,282	1,122	896	802
Enterprise Value High	860	584	752	1,034	1,501	1,780	1,838	4,384	4,117	7,506	7,070	3,382	1,602	1,364	1,084
Enterprise Value Low	449	373	354	692	941	980	1,004	2,820	2,658	2,697	1,863	1,295	841	639	582

Shares Outstanding	36	36	37	38	39	41	49	51	52	53	51	50	52	54	52
Diluted Weighted Avg Shares	36	36	37	46	47	49	50	51	52	54	54	50	51	53	57
Basic Weighted Avg Shares	36	36	36	37	39	40	42	50	52	53	54	50	51	53	54
Revenue per Share	5.68	5.98	7.12	8.38	9.64	8.6	11.73	14.08	19.1	27.75	30.64	21.48	19.98	19.12	13.18
EBITDA per Share	1.16	1.41	1.71	3.26	4.58	3.58	3.99	3.03	4.37	10.49	9.47	-0.4	-1.49	0.52	3.89
Operating Income per Share	0.9	1.1	1.18	2.39	3.67	2.63	2.97	1.79	2.22	8.32	7.16	-3.26	-3.94	-1.54	2.1
Basic EPS, GAAP	0.65	0.65	0.86	0.98	1.63	1.29	1.98	1.25	1.06	5.8	4.1	-4.22	-14.85	-3.6	0.98
Basic EPS from Cont Ops	0.45	0.5	0.84	1.45	2.37	1.56	1.98	1.25	1.06	5.8	4.1	-4.22	-14.85	-3.6	0.98
Diluted EPS, GAAP	0.64	0.65	0.85	0.8	1.33	1.05	1.64	1.22	1.04	5.68	4.06	-4.22	-14.85	-3.6	0.93
Diluted EPS from Cont Ops	0.45	0.5	0.82	1.18	1.93	1.27	1.64	1.22	1.04	5.68	4.06	-4.22	-14.85	-3.6	0.93
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.34	1.1	2.68	3.01	1.1	1.36	4.98	0.83	3.65	10.19	5.99	-0.68	-4.03	1.11	3.19
Free Cash Flow per Basic Share	-1.17	-0.39	1.52	2.19	-0.06	-0.54	3.67	-0.6	1.96	7.5	1.8	-3.43	-5.04	0.68	2.93
Cash & Equivalents per Share	4.09	3.93	4.95	7.51	7.99	6.76	4.26	2.24	3.26	11.79	10.77	12.83	2.18	1.88	3.84
Book Value per Share	5.52	6.11	6.95	7.72	9.1	6.33	8.06	7.33	8.19	13.8	17.76	14.75	-0.42	-4.01	-2.99
Tangible Book Value per Share	10.09	10.94	11.14	10.22	14.96	12.97	17.78	-1.21	1.55	9.81	14.62	8.8	1.62	-0.35	1.61

Emergent BioSolutions Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)